TriSalus Life Sciences Inc
NASDAQ:TLSI
Cash Flow Statement
Cash Flow Statement
TriSalus Life Sciences Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
5
|
8
|
10
|
9
|
6
|
2
|
(22)
|
(24)
|
(59)
|
(72)
|
(54)
|
(55)
|
(30)
|
(27)
|
(31)
|
(40)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
5
|
5
|
6
|
7
|
9
|
|
| Other Non-Cash Items |
(8)
|
(11)
|
(13)
|
(12)
|
(9)
|
(6)
|
(2)
|
(16)
|
8
|
11
|
6
|
17
|
(2)
|
(1)
|
5
|
15
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Change in Working Capital |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
(3)
|
1
|
0
|
(7)
|
(6)
|
(10)
|
(7)
|
(2)
|
3
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
-13%
|
(2)
-11%
|
(2)
+1%
|
(3)
-27%
|
(3)
-10%
|
(21)
-610%
|
(42)
-99%
|
(51)
-19%
|
(60)
-19%
|
(54)
+10%
|
(44)
+19%
|
(41)
+7%
|
(34)
+16%
|
(29)
+17%
|
(21)
+25%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
233
|
233
|
233
|
232
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
+17%
|
0
+114%
|
0
+193%
|
233
+52 900%
|
233
0%
|
233
+0%
|
231
-1%
|
(2)
N/A
|
(2)
-23%
|
(2)
-10%
|
(1)
+53%
|
(0)
+66%
|
(1)
-188%
|
(1)
+16%
|
(1)
-1%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
(232)
|
0
|
(223)
|
(223)
|
9
|
12
|
7
|
13
|
16
|
13
|
31
|
25
|
|
| Net Issuance of Debt |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
(0)
|
(0)
|
25
|
25
|
25
|
35
|
10
|
10
|
|
| Other |
1
|
1
|
1
|
1
|
0
|
1
|
5
|
45
|
45
|
44
|
38
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Cash from Financing Activities |
1
N/A
|
1
+50%
|
1
+78%
|
2
+14%
|
(231)
N/A
|
(230)
+0%
|
(217)
+6%
|
(177)
+18%
|
55
N/A
|
57
+4%
|
69
+22%
|
35
-49%
|
38
+8%
|
44
+17%
|
39
-12%
|
33
-15%
|
|
| Change in Cash | |||||||||||||||||
| Net Change in Cash |
(1)
N/A
|
(1)
+5%
|
(1)
+46%
|
(0)
+88%
|
(0)
+29%
|
0
N/A
|
(5)
N/A
|
12
N/A
|
2
-79%
|
(5)
N/A
|
13
N/A
|
(10)
N/A
|
(3)
+67%
|
9
N/A
|
10
+9%
|
11
+14%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(2)
N/A
|
(2)
-13%
|
(2)
-11%
|
(2)
+1%
|
(3)
-27%
|
(3)
-10%
|
(21)
-611%
|
(43)
-99%
|
(51)
-20%
|
(61)
-19%
|
(55)
+10%
|
(45)
+19%
|
(41)
+7%
|
(36)
+14%
|
(30)
+17%
|
(22)
+25%
|
|